Diamide compounds having muscarinic receptor antagonist and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/12 (2006.01) A61K 31/444 (2006.01) A61P 11/00 (2006.01) A61P 11/08 (2006.01)

Patent

CA 2758505

This invention relates to a compound of formula I; or a pharmaceutically acceptable salt thereof. Such compounds possess both muscarinic receptor antagonist and .beta.2 adrenergic receptor agonist activities. The invention also relates to pharmaceu-tical compositions comprising such compounds, processes and intermediates for preparing such compounds, and methods of using such compounds as bronchodilating agents to treat pulmonary disorders.

L'invention concerne un composé de formule I; ou un sel de celui-ci pharmaceutiquement acceptable. Ces composés possèdent les activités aussi bien de l'antagoniste du récepteur muscarinique que de l'agoniste des récepteurs adrénergiques bêta2. L'invention concerne également des compositions pharmaceutiques comprenant ces composés, des processus et des intermédiaires pour la préparation de ces composés; elle concerne en outre des procédés d'utilisation de ces composés comme agents bronchodilatateurs pour le traitement de troubles pulmonaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Diamide compounds having muscarinic receptor antagonist and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diamide compounds having muscarinic receptor antagonist and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diamide compounds having muscarinic receptor antagonist and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1442073

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.